Antiviral Research
Издатель: Elsevier · ISSN 0166-3542 · 25 статей
- LXN exerts antiviral effects by inhibiting the binding of HMGB1 to the viral genome
- Intracellular Zn2+ levels regulate susceptibility to hepatitis B virus infection by modulating NTCP-mediated viral entry
- NF-κB–driven repression of Nrf2 facilitates HSV-1 replication in SH-SY5Y neuroblastoma and HeLa epithelial cells
- The Golgi-resident protein ACBD3 facilitates the interaction between enteroviral 3A proteins and Exportin-1
- A novel antiviral drug candidate acts by binding to the hemagglutinin stem
- N70 S/Y155H combined mutation of neuraminidase of avian influenza H9N2 virus confers oseltamivir and zanamivir resistance and pathogenicity to mice
- Novel phorbol-12-O-octoate derivatives exert a dual effect by inhibiting de novo HIV-1 infection and reactivating latent virus
- Identification of novel HIV-1 capsid protein (CA) inhibitors (ACAi-010 and ACAi-024) that promote hyper-stabilization of HIV-1 CA in vitro
- Molnupiravir, first small molecule therapeutic to demonstrate therapeutic efficacy against Venezuelan equine encephalitis virus in the cynomolgus macaque model
- Toll-like receptor 7 and interferon-α synergy establishes a positive feedback loop to potentiate antiviral immunity in chronic hepatitis B
- Antiviral activity of amenamevir alone and in combination with ganciclovir against equine herpesvirus 1
- Inhibition of Porcine Cytomegalovirus/Porcine Roseolovirus (PCMV/PRV) replication with antiviral compounds
- Nucleoside analogs containing an imino-ribitol sugar exhibit a distinctive pattern of interference with RNA synthesis by the Dengue virus polymerase
- Meeting report: 39th International Conference on Antiviral Research in Prague, Czech Republic, April 27–May 1, 2026
- RNA-dependent RNA polymerase (RdRp): Structure, function, and antiviral targeting in RNA viruses
- WG-am combinations restore antiviral potency against fostemsavir and lenacapavir-resistant HIV-1
- Ferritin-displayed engineered sCAR1 nanoparticles as a receptor-decoy antiviral strategy against Coxsackievirus B-associated inflammation
- Corrigendum to “Construction of a suckling mouse model based on an EV-C96 clinical isolate and its application in drug screening and vaccine development” [Antivir. Res. 254 (2026) 106511]
- Editorial - Antibody-based antiviral therapies: a wave of novel approvals is coming up
- Divergent functional checkpoints determine epitope-specific ADE outcomes of SARS-CoV-2 entry
- Novel nirmatrelvir-resistance mutations in SARS-CoV-2 Mpro using a yeast screening platform
- Metabolite screening identifies potent antivirals that mitigate Zika virus-induced ocular pathology
- Nanobodies targeting the conserved post-fusion six-helix bundle core provide protective effects against SARS-CoV-2 infection and immunopathology
- Small molecules inhibit hepatitis B and D virus infection by binding the small surface antigen
- Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity